Sarah Kiely | Director, IR |
Mark Enyedy | CEO |
Anna Berkenblit | Chief Medical Officer |
Dave Johnston | CFO |
Jessica Fye | JPMorgan |
Andy Hsieh | William Blair |
Debjit Chattopadhyay | H.C. Wainwright |
Biren Amin | Jefferies |
Mara Goldstein | Cantor Fitzgerald |
Good day everyone and welcome to ImmunoGen First Quarter 2018 Financial Results Conference Call. Today’s call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to today’s host, Sarah Kiely, Investor Relations. Please go ahead.
Good morning and thank you for joining today’s call.